SB
BMY icon

Strategic Blueprint’s Bristol-Myers Squibb BMY Stock Holding History

Strategic Blueprint’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
5,572
-579
-9% -$33.2K 0.02% 551
2026
Q1 		$373K Buy
6,151
+59
+1% +$3.44K 0.02% 472
2025
Q4 		$329K Sell
6,092
-4,589
-43% -$221K 0.02% 498
2025
Q3 		$482K Sell
10,681
-1,660
-13% -$77.5K 0.02% 484
2025
Q2 		$571K Buy
12,341
+92
+0.8% +$4.52K 0.03% 422
2025
Q1 		$747K Sell
12,249
-435
-3% -$25.4K 0.04% 342
2024
Q4 		$717K Buy
12,684
+502
+4% +$28K 0.04% 326
2024
Q3 		$630K Sell
12,182
-4,314
-26% -$202K 0.04% 352
2024
Q2 		$685K Sell
16,496
-797
-5% -$35.7K 0.05% 308
2024
Q1 		$938K Buy
17,293
+7,578
+78% +$386K 0.07% 252
2023
Q4 		$498K Buy
9,715
+4,275
+79% +$224K 0.04% 353
2023
Q3 		$316K Buy
5,440
+431
+9% +$26.4K 0.03% 404
2023
Q2 		$320K Buy
5,009
+158
+3% +$10.6K 0.03% 406
2023
Q1 		$336K Buy
4,851
+563
+13% +$39.7K 0.03% 375
2022
Q4 		$309K Buy
4,288
+693
+19% +$52.3K 0.04% 391
2022
Q3 		$256K Buy
3,595
+149
+4% +$10.8K 0.03% 413
2022
Q2 		$265K Sell
3,446
-995
-22% -$75.8K 0.03% 403
2022
Q1 		$324K Sell
4,441
-13
-0.3% -$873 0.04% 372
2021
Q4 		$278K Sell
4,454
-2,896
-39% -$170K 0.04% 397
2021
Q3 		$435K Buy
7,350
+3,076
+72% +$203K 0.07% 261
2021
Q2 		$286K Buy
+4,274
New +$279K 0.04% 311
2019
Q4 		– Sell
-89
Closed -$5K – 130
2019
Q3 		$5K Buy
+89
New +$4.18K ﹤0.01% 353

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Strategic Blueprint's BMY Position: Q2 2026 in Review

Strategic Blueprint reduced its Bristol-Myers Squibb (BMY) stake by 9.4% in Q2 2026, selling an estimated $33.2K and leaving 5,572 shares worth $321K. The position accounts for 0.02% of the portfolio, ranked #551.

Strategic Blueprint first reported a position in BMY in Q3 2019 and has held it in 22 quarters since. The position peaked at $938K in Q1 2024. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Strategic Blueprint held 5,572 shares of Bristol-Myers Squibb worth $321K as of Q2 2026.
  • Strategic Blueprint sold 579 Bristol-Myers Squibb shares in Q2 2026, an estimated $33.2K.
  • Bristol-Myers Squibb made up 0.02% of Strategic Blueprint's portfolio in Q2 2026, its #551 holding.
  • Strategic Blueprint first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 22 quarters since.
  • Strategic Blueprint's Bristol-Myers Squibb position peaked at $938K in Q1 2024.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Strategic Blueprint's 13F filing for Q2 2026, filed 23 Jul 2026.